NCT00500409View on ClinicalTrials.gov

Safety and Efficacy of OSTEOFORM (rhPTH [1-34]) in Increasing Bone Mineral Density in Osteoporosis

PHASE3CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

December 31, 2006

Study Completion Date

July 31, 2007

Conditions
Osteoporosis
Interventions
DRUG

Osteoform

Administer Osteoform 20 µg daily subcutaneously and 1000 mg calcium and 500 IU vitamin D orally for 180 days

DRUG

SHELCAL

Administer calcium and vitamin D (1000 mg calcium and 500 IU vitamin D) orally for 180 days

Trial Locations (6)

Unknown

Apollo Hospitals, Hyderabaad

CARE Hospitals, Hyderabaad

Medwin Hospital, Hyderabaad

MS Ramaiah Medical College, Bangalore

P.D. Hinduja Hospital and Medical Research Center, Mumbai

Apollo Hospitals, Chennai

All Listed Sponsors
lead

Virchow Group

INDUSTRY

NCT00500409 - Safety and Efficacy of OSTEOFORM (rhPTH [1-34]) in Increasing Bone Mineral Density in Osteoporosis | Biotech Hunter | Biotech Hunter